Biopsy Needle Market Forecast To Reach $2.06 Billion By 2030: Key Growth Drivers And Industry Trends
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Biopsy Needle Market Forecast: Value Set To Climb From $1.52 Billion To $2.06 Billion
The biopsy needle market has experienced robust growth in recent years. It is projected to expand from $1.41 billion in 2025 to $1.52 billion in 2026, at a compound annual growth rate (CAGR) of 7.8%. This historical growth can be attributed to factors including the continued reliance on traditional core needle biopsy methods, the limited availability of vacuum-assisted biopsy devices, the increasing prevalence of cancer cases, an expansion in hospital and surgical center infrastructure, and a growing awareness of early diagnostic procedures.
The biopsy needle market size is expected to experience significant expansion over the next few years. It is projected to grow to $2.06 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. This increase during the forecast period is primarily driven by technological advancements in image-guided and vacuum-assisted devices, the creation of innovative disposable needle designs, the proliferation of diagnostic clinics and pathology laboratories, increasing investment in research and academic institutions, and the integration of AI and digital tools for precise diagnostics. Significant trends anticipated in the forecast period encompass the increasing adoption of image-guided biopsy procedures, a rising preference for disposable biopsy needles, the growth of minimally invasive diagnostic techniques, the expansion of cancer and tumor screening programs, and an enhanced focus on patient safety and sterility standards.
Get A Free Sample Report With In-Depth Market Insights:
Biopsy Needle Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The escalating preference for minimally invasive procedures is projected to spur the expansion of the biopsy needle market moving forward. These medical techniques are carried out through minor incisions or openings, thereby reducing patient trauma and accelerating recovery. The appeal of minimally invasive surgical procedures stems from their capacity to offer quicker recuperation periods, diminished complication risks, less pain, and smaller scars, thus making them more attractive to patients seeking swifter and safer treatment options. Biopsy needles are instrumental in minimally invasive procedures, enabling precise tissue sampling and reducing the necessity for extensive surgical intervention. They contribute to faster diagnoses and recovery times, enhancing patient comfort and improving procedural efficiency. For example, in November 2024, the American Society of Plastic Surgeons, a US-based non-profit organization, stated that the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, representing a 7% increase from 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is a key factor driving the growth of the biopsy needle market.
Biopsy Needle Market Breakdown By Product Type And Application
The biopsy needle market covered in this report is segmented –
1) By Usage: Disposable, Non-Disposable
2) By Product: Needle Based Biopsy Guns, Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices
3) By Procedure: Image-Guided Procedures, Non-Image-Guided Procedures
4) By Application: Cancer Or Tumor, Breast, Lung, Prostate, Colon, Stomach, Liver, Rectum, Cervix Uteri, Other Applications
5) By End-User: Hospitals And Surgical Centers, Diagnostic Clinics And Pathology Laboratories, Ambulatory Care Centers, Research And Academic Institutes
Subsegments:
1) By Disposable: Coaxial Biopsy Needles, Chiba Needles, Jamshidi Needles
2) By Non-Disposable: Reusable Tru-Cut Biopsy Needles, Reusable Menghini Needles, Reusable Francine Needles
Biopsy Needle Market Innovation Trends Shaping Future Development
Major companies in the biopsy needle market are concentrating on developing technologically advanced products, such as semi-automatic core biopsy instruments, to improve precision and ease of tissue sampling in minimally invasive procedures. Semi-automatic core biopsy instruments are medical devices that utilize a spring-loaded mechanism to quickly and accurately gather tissue samples with minimal manual effort during a biopsy procedure. For example, in May 2023, Argon Medical Devices Inc., a US-based medical device manufacturer, introduced the SuperCore Advantage semi-automatic biopsy instrument. This is a semi-automatic, disposable core biopsy needle designed to provide consistent, high-quality tissue samples for accurate diagnosis. It incorporates an ergonomic design, a sharp cutting edge for clean specimen retrieval, and an adjustable throw length to suit varying lesion depths. The device also improves biopsy precision while minimizing patient discomfort, offering better diagnostic options for patients.
Biopsy Needle Market Key Participants And Competitive Landscape
Major companies operating in the biopsy needle market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., Cook Medical, Halma plc, Merit Medical Systems Inc., ConMed Corporation, Devicor Medical Products Inc., Shandong Weigao Group Medical Polymer Company Limited, Remington Medical Inc., Advin Health Care, Nikotech Healthcare Pvt. Ltd., Argon Medical Devices Inc., Geotek Medical Products Co. Ltd., Biomedical Srl, Hakko Co. Ltd., INRAD Inc.
View The Full Biopsy Needle Market Report:
Biopsy Needle Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the biopsy needle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopsy needle market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
